Capricor Therapeutics, Inc. financial data

Symbol
CAPR on Nasdaq
Location
8840 Wilshire Blvd, 2 Nd Floor, Beverly Hills, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 11, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 563 % +317%
Debt-to-equity 23.4 % -91.1%
Return On Equity -62.7 % +71.5%
Return On Assets -50.8 % +16.5%
Operating Margin -191 % -99.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 45.7M shares +40.5%
Common Stock, Shares, Outstanding 45.7M shares +42.9%
Entity Public Float 140M USD +17%
Common Stock, Value, Issued 45.7K USD +42.9%
Weighted Average Number of Shares Outstanding, Basic 45.7M shares +43.6%
Weighted Average Number of Shares Outstanding, Diluted 45.7M shares +43.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 22.3M USD -11.5%
Research and Development Expense 67.3M USD +54.5%
General and Administrative Expense 19.5M USD +43.4%
Operating Income (Loss) -73.4M USD -145%
Nonoperating Income (Expense) 3.43M USD +67%
Net Income (Loss) Attributable to Parent -70M USD -150%
Earnings Per Share, Basic -1 USD/shares -78.7%
Earnings Per Share, Diluted -1 USD/shares -78.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 23.2M USD +117%
Marketable Securities, Current 99.6M USD +430%
Cash, Cash Equivalents, and Short-term Investments 123M USD +316%
Assets, Current 124M USD +305%
Property, Plant and Equipment, Net 8M USD +42.3%
Operating Lease, Right-of-Use Asset 939K USD -43.8%
Assets 134M USD +249%
Accounts Payable, Current 4.81M USD
Employee-related Liabilities, Current 4.08M USD
Accrued Liabilities, Current 7.36M USD
Contract with Customer, Liability, Current 12M USD -22%
Liabilities, Current 28.4M USD +27%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 195K USD -81.4%
Liabilities 28.6M USD +6.79%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.39M USD +795%
Retained Earnings (Accumulated Deficit) -250M USD -38.8%
Stockholders' Equity Attributable to Parent 105M USD +813%
Liabilities and Equity 134M USD +249%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.43M USD -407%
Net Cash Provided by (Used in) Financing Activities 50.4K USD -97.8%
Net Cash Provided by (Used in) Investing Activities 23.9M USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 45.7M shares +42.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 23.2M USD +117%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Operating Lease, Liability 1.04M USD -43.2%
Depreciation 1.63M USD +28%
Payments to Acquire Property, Plant, and Equipment 896K USD +47.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -68.7M USD -146%
Lessee, Operating Lease, Liability, to be Paid 1.09M USD -45.2%
Property, Plant and Equipment, Gross 12.2M USD +43%
Operating Lease, Liability, Current 850K USD +7.17%
Lessee, Operating Lease, Liability, to be Paid, Year Two 635K USD -30.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 635K USD -30.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 50.6K USD -68.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 635K USD +15.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Operating Lease, Payments 902K USD -0.87%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 405K USD +22.3%
Share-based Payment Arrangement, Expense 13.7M USD +52.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%